Active	Status	Sponsor type	Region	Phase	Filter
8 Active 1 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Larsen, Cassie
MINT, NCT05799755: Myositis Interstitial Lung Disease Nintedanib Trial	Active, not recruiting	4	70	US	Nintedanib, OFEV, Placebo, Standard of Care	Rohit Aggarwal, MD, Boehringer Ingelheim	Myositis Associated Interstitial Lund Disease (MA-ILD)	07/25	12/25
TETON, NCT04708782: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis May 2024 - Aug 2024 : Topline data for IPF Jan 2023 - Mar 2023 : Enrollment completion of TETON trial for IPF	Recruiting	3	576	Canada, US	Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer	United Therapeutics	Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease	06/25	06/25
Martinez, Joseph
No trials found
Suciu, Tyler
No trials found
Ahlstrom, Jennifer
No trials found
Smith, Andreia
No trials found